The whiners can sell their shares. Good riddance to you. I can wait for a Christmas present to show itself this year. Nader said... approval possible by end of year. Which will be first? Covid or HIV? I am good with that race. I am also good with if he is a month off due to whatever reason that could come up. Some complainers just blow me away. Like they could jump in and run this company better. If that’s who you are? I am holding up three fingers and asking you to read between the lines.
We didn’t have the best news we expected today. But it was more news that de-risks our investment in my opinion. The things I liked...
Trial continues with no major modification! That’s huge! Slight added mod of 42 days to improve our strength in the next interim look. I am good with this help. De-risking!
Looks like HIV in U.K.,EU and Canada is going to be submitted soon. Like a week for U.K. and the next week for Canada. This is great news... yet we hear complaining? Whining? Really? More de-risking.
I am happy to hear our updates on other indications and to see our focus is moving forward in all that matters to the investor. MTNBC, Basket Trial (BTD?), GVHD, Nash and long haulers. I hope these are not slowed and continue to further the bottom line of this company. I am excited still to see just how many indications will get approved. That’s why I will stay in this investment.
Covid is a possible big time revenue depending on how we can ramp up our supply chain. That’s the bottle neck we have. Solve that problem and look out on the revenue front. I am a firm believer we won’t have a long term vaccine. Sad about it but reality is this Covid Coronavirus mutates like HIV. Not encouraging.
Ask Gilead what they thought they could make on Covid. There are just another domino that just fell in the wrong direction. Opens up a pretty big market for a drug that works and we know we do. Just need the p value to show it. It’s a numbers game and we have a small budget in comparison to others but somehow on our beer budget we will be popping champagne bottles. Just imagine that. Our time is coming in many ways. If you were here for just Covid. You haven’t done enough D&D and should know the over 60 possible indications this inflammation controller/ autoimmune regulator will be approved for. Yet we have reasons to complain... like I said before. The complainers can leave and you won’t be missed... that’s a guarantee. Time is still on our side. We are still in the lead for first approval in severe/critical. But that doesn’t really matter first or second. There will be lots of revenue for whomever is in the approval club when all is said and done.
Now the whiners can pick apart my post... will it make me sell shares? Nope...
We didn’t have the best news we expected today. But it was more news that de-risks our investment in my opinion. The things I liked...
Trial continues with no major modification! That’s huge! Slight added mod of 42 days to improve our strength in the next interim look. I am good with this help. De-risking!
Looks like HIV in U.K.,EU and Canada is going to be submitted soon. Like a week for U.K. and the next week for Canada. This is great news... yet we hear complaining? Whining? Really? More de-risking.
I am happy to hear our updates on other indications and to see our focus is moving forward in all that matters to the investor. MTNBC, Basket Trial (BTD?), GVHD, Nash and long haulers. I hope these are not slowed and continue to further the bottom line of this company. I am excited still to see just how many indications will get approved. That’s why I will stay in this investment.
Covid is a possible big time revenue depending on how we can ramp up our supply chain. That’s the bottle neck we have. Solve that problem and look out on the revenue front. I am a firm believer we won’t have a long term vaccine. Sad about it but reality is this Covid Coronavirus mutates like HIV. Not encouraging.
Ask Gilead what they thought they could make on Covid. There are just another domino that just fell in the wrong direction. Opens up a pretty big market for a drug that works and we know we do. Just need the p value to show it. It’s a numbers game and we have a small budget in comparison to others but somehow on our beer budget we will be popping champagne bottles. Just imagine that. Our time is coming in many ways. If you were here for just Covid. You haven’t done enough D&D and should know the over 60 possible indications this inflammation controller/ autoimmune regulator will be approved for. Yet we have reasons to complain... like I said before. The complainers can leave and you won’t be missed... that’s a guarantee. Time is still on our side. We are still in the lead for first approval in severe/critical. But that doesn’t really matter first or second. There will be lots of revenue for whomever is in the approval club when all is said and done.
Now the whiners can pick apart my post... will it make me sell shares? Nope...
24
1
